Synopsis
Synopsis
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aneurin
2. Mononitrate, Thiamine
3. Thiamin
4. Thiamine
5. Thiamine Mononitrate
6. Vitamin B 1
7. Vitamin B1
1. 532-43-4
2. Thiamine Mononitrate
3. Vitamin B1 Nitrate
4. Vitamin B1 Mononitrate
5. Aneurine Mononitrate
6. Betabion Mononitrate
7. Thiamine Nitrate (salt)
8. Thiamin Mononitrate
9. Thiamine Mononitrate [usp]
10. Vitamin B1 (as Thiamine Nitrate)
11. 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol;nitrate
12. 8k0i04919x
13. Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, Nitrate (salt)
14. Aneurine Nitrate
15. Thiamine Mononitrate (usp)
16. 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium Nitrate
17. Thiaminenitrate
18. Vitamin B(sub 1) Nitrate
19. Mononitrato De Tiamina
20. Einecs 208-537-4
21. Thiamin Nitrate
22. Unii-8k0i04919x
23. Thiamini Mononitras
24. Vitanon (tn)
25. Mfcd00036330
26. Thiamine Nitrate, 95%
27. Thiamine Mononitrate,(s)
28. Thiamine Nitrate (jp17)
29. 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium Nitrate
30. 3-(4-amino-2-methylpyrimidyl-5-methyl)-4-methyl-5,beta-hydroxyethylthiazolium Nitrate
31. Dsstox_cid_18762
32. Dsstox_rid_79391
33. Dsstox_gsid_38762
34. Schembl60971
35. Thiamine Nitrate, Aldrichcpr
36. Thiamine Nitrate [jan]
37. Thiamine Nitrate [inci]
38. Chembl2104496
39. Dtxsid4038762
40. Thiamine Mononitrate [mi]
41. Thiamine Nitrate [mart.]
42. Thiamine Mononitrate [fcc]
43. Hy-b2223
44. Thiamine Mononitrate [vandf]
45. Tox21_302321
46. Thiamine Mononitrate [who-dd]
47. Thiamine Mononitrate [who-ip]
48. Akos015918391
49. Akos015961239
50. Thiamine Nitrate [ep Impurity]
51. Cs-7673
52. Thiamine Mononitrate, >=98% (hplc)
53. Thiamine Nitrate [ep Monograph]
54. Ncgc00255700-01
55. 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium Nitrate (salt)
56. Ac-13450
57. As-15189
58. Cas-532-43-4
59. Thiamine Nitrate (salt) [who-ip]
60. Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethyl-, Nitrate (salt)
61. Thiazolium,3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-,nitrate (salt)
62. Thiamini Mononitras [who-ip Latin]
63. Thiamine Mononitrate [usp Monograph]
64. Ft-0657793
65. T0182
66. 3-((4-amino-2-methylpyrimidin-5-yl)methyl)
67. D03277
68. E78994
69. A829473
70. Q7783874
71. Thiamine Mononitrate 10 Microg/ml In Acetonitrile:water
72. Thiamine Mononitrate, British Pharmacopoeia (bp) Reference Standard
73. Thiamine Nitrate, European Pharmacopoeia (ep) Reference Standard
74. Thiamine Nitrate, Pharmaceutical Secondary Standard; Certified Reference Material
75. 3-((4-amino-2-methylpyrimidin-5-yl)methyl)-5-(2-hydroxyethyl)-4-methylthiazol-3-ium Nitrate
76. Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-, Nitrate (1:1)
77. Thiazolium, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2hydroxyethyl)-4-m-ethyl-, Nitrate (salt)
| Molecular Weight | 327.36 g/mol |
|---|---|
| Molecular Formula | C12H17N5O4S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 327.10012521 g/mol |
| Monoisotopic Mass | 327.10012521 g/mol |
| Topological Polar Surface Area | 167 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 287 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
43
PharmaCompass offers a list of Thiamine Mononitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Thiamine Mononitrate manufacturer or Thiamine Mononitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thiamine Mononitrate manufacturer or Thiamine Mononitrate supplier.
PharmaCompass also assists you with knowing the Thiamine Mononitrate API Price utilized in the formulation of products. Thiamine Mononitrate API Price is not always fixed or binding as the Thiamine Mononitrate Price is obtained through a variety of data sources. The Thiamine Mononitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AC-13450 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC-13450, including repackagers and relabelers. The FDA regulates AC-13450 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC-13450 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AC-13450 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AC-13450 supplier is an individual or a company that provides AC-13450 active pharmaceutical ingredient (API) or AC-13450 finished formulations upon request. The AC-13450 suppliers may include AC-13450 API manufacturers, exporters, distributors and traders.
click here to find a list of AC-13450 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AC-13450 DMF (Drug Master File) is a document detailing the whole manufacturing process of AC-13450 active pharmaceutical ingredient (API) in detail. Different forms of AC-13450 DMFs exist exist since differing nations have different regulations, such as AC-13450 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AC-13450 DMF submitted to regulatory agencies in the US is known as a USDMF. AC-13450 USDMF includes data on AC-13450's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AC-13450 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AC-13450 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The AC-13450 Drug Master File in Japan (AC-13450 JDMF) empowers AC-13450 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the AC-13450 JDMF during the approval evaluation for pharmaceutical products. At the time of AC-13450 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of AC-13450 suppliers with JDMF on PharmaCompass.
A AC-13450 CEP of the European Pharmacopoeia monograph is often referred to as a AC-13450 Certificate of Suitability (COS). The purpose of a AC-13450 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AC-13450 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AC-13450 to their clients by showing that a AC-13450 CEP has been issued for it. The manufacturer submits a AC-13450 CEP (COS) as part of the market authorization procedure, and it takes on the role of a AC-13450 CEP holder for the record. Additionally, the data presented in the AC-13450 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AC-13450 DMF.
A AC-13450 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AC-13450 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of AC-13450 suppliers with CEP (COS) on PharmaCompass.
AC-13450 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AC-13450 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AC-13450 GMP manufacturer or AC-13450 GMP API supplier for your needs.
A AC-13450 CoA (Certificate of Analysis) is a formal document that attests to AC-13450's compliance with AC-13450 specifications and serves as a tool for batch-level quality control.
AC-13450 CoA mostly includes findings from lab analyses of a specific batch. For each AC-13450 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AC-13450 may be tested according to a variety of international standards, such as European Pharmacopoeia (AC-13450 EP), AC-13450 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AC-13450 USP).
